Green Park & Golf Ventures

What Green Park & Golf Ventures does

Green Park & Golf Ventures (GPG) is a Dallas-based, early-stage venture capital firm founded in 2011 by Dr. Clay Heighten, an emergency medicine physician, and Carl Soderstrom, a healthcare operator. The firm invests primarily in early-stage healthcare companies across medical devices, biotech, healthcare IT, digital health, and therapeutics, with approximately 80% of its portfolio concentrated in healthcare and the remainder in technology. GPG typically invests $500,000 to $2,000,000 per company at Series Seed through Series C stages, targeting startups with experienced management teams and disruptive technologies.

The firm's core products are two closed-end healthcare venture funds: GPG HOF ($9.1M closed 2018) and GPG HOF II ($20.5M closed 2021), plus Special Purpose Vehicles (SPVs) that allow individual investors to co-invest alongside the funds. Revenue is generated through traditional VC mechanics: 2% management fees on committed capital, 20% carried interest on successful exits, and SPV-level management and advisory fees. Deal flow is sourced through the founders' operating track record (building and selling MedicalEdge and PhyServe to Texas Health Resources for $9B combined), the firm's co-founding role in the Health Wildcatters healthcare accelerator, alignment with CPRIT-funded oncology companies, and direct submissions via a company intake survey.

GPG operates three Texas offices—Dallas (headquarters, founded 2011), Houston (opened 2019 with Managing Partner Daniel S. Parsley), and Austin (opened Q4 2023 with Investment Partner Claire England)—and maintains a small team of fewer than ten professionals including a Chief Scientific Officer, a Partner responsible for financing strategy, and a Head of Investor Relations. The firm does not develop proprietary technology and does not rely on AI as a core capability; its competitive differentiation is built on healthcare operating expertise, network-driven deal flow, and ecosystem leadership within the Texas startup community.

Name

Green Park & Golf Ventures

Legal name

Green Park & Golf Ventures, LLC

Website

https://gpgventures.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Green Park & Golf Ventures is a Dallas-based early-stage venture capital firm founded in 2011 that invests $500K-$2M in healthcare startups across medical devices, biotech, digital health, and therapeutics via two closed-end funds totaling approximately $29.6M in AUM.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Financial Vehicles (52599), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

Keywords

• Venture capital investing
• Healthcare investment funds
• Early-stage financing
• Medical device investment
• Portfolio management services

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Fund Management Fees: Management fees charged on committed capital in the Healthcare Opportunities Funds (HOF and HOF II). These provide steady revenue to operate the firm.
2. Carried Interest: Performance-based carried interest from fund investments upon successful exits of portfolio companies. Aligns GP incentives with LPs for outlier returns.
3. SPV Investment Returns: Individual investors pool into single-purpose LLCs to invest alongside the fund, providing additional management and advisory fee opportunities.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Green Park & Golf Ventures is an early-stage venture capital firm that invests $500,000 to $2,000,000 in seed-through-Series-C healthcare companies, with approximately 80% of capital directed to medical devices and healthcare IT and 20% to technology. The firm raises blind-pool limited partnership funds (GPG HOF closed at $9.1M in 2018 and GPG HOF II at $20.5M in 2021) and provides portfolio companies with strategic guidance, board involvement, and network access in addition to capital.

Product overview

Green Park & Golf Ventures is an early-stage venture capital firm offering a unified platform of investment products. The core offering consists of the GP&G Healthcare Opportunities Fund (HOF) and GP&G HOF II, which pool investor capital to make healthcare-focused investments. The firm provides strategic solutions, financial backing, and network access to portfolio companies, with typical investment ranges of $500,000 to $2,000,000. The investment strategy targets medical-related startups with compassionate leadership, disruptive ideas, and large market opportunities with high barriers to entry.

Differentiator

Problem solved

Functional benefit

Products and services

• GP&G Healthcare Opportunities Fund (HOF) A healthcare-focused blind-pool limited partnership fund that pools capital from family offices and accredited investors to make investments in early-stage healthcare companies, with Green Park & Golf retaining sole discretion over investment decisions.
• GP&G HOF II The successor healthcare opportunities fund, exclusively investing in healthcare and healthcare-related portfolio companies, with GPG maintaining sole discretion over deployment and realization.
• Portfolio Company Investment Services Equity capital, strategic guidance, and network access provided to portfolio companies, with typical investments of $500,000 to $2,000,000 used for startup or growth capital at seed through Series C stages, including active board involvement.

Quantifiable outcome

• 91 investments in 61+ companies since 2011
• +2 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Health WildcatterscoreStrategic or Co-development PartnerGPG Ventures is a partner and strong supporter of Dallas-based Health Wildcatters, a startup accelerator focused on healthcare and life science startups. The partnership provides deal flow access and ecosystem positioning. GPG co-founders are co-founders of Health Wildcatters.
• Cancer Prevention & Research Institute of Texas (CPRIT)coreStrategic or Co-development PartnerCPRIT is a $6 billion initiative to fund the fight against cancer. GP&G Ventures supports CPRIT-funded companies including Stingray Therapeutics, Iterion Therapeutics, Onconano Medicine, Barricade Therapeutics, and NovaScan, representing significant portfolio alignment.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• TMC (Texas Medical Center) Innovation: Houston-based healthcare innovation hub affiliated with the world's largest medical center; a sourcing and partnership peer for Texas healthcare deals with partial overlap in digital health and medtech, often interfacing with GPG's Houston office.
• Portal Innovations: Early-stage life sciences and healthcare investor with lab-enabled model in select cities; comparable in stage and healthcare focus, but operates in different geographies (Chicago, Atlanta) rather than competing head-to-head in Texas.

Direct peers

• Health Wildcatters: Dallas-based healthcare startup accelerator co-founded by GPG's partners; while accelerator-led rather than fund-led, it shares the same Texas healthcare thesis, deal pipeline, and management overlap, making it the closest direct comparable.
• Capital Factory: Texas-based accelerator/seed investor with center of gravity in Austin; overlaps with GPG's Austin office and shares deal flow in Texas early-stage healthcare and tech, often co-investing alongside GPG.
• Central Texas Angel Network (CTAN): Angel network previously led by GPG's Austin partner Claire England (#1 most active U.S. angel group, $75M deployed); operates in the same Texas early-stage healthcare ecosystem and serves as both a co-investor and deal-flow source for GPG.
• LiveOak Venture Partners: Austin-based early-stage VC with similar Texas-centric thesis and seed-to-Series A focus; comparable fund size and stage, often competing for the same Texas healthcare and B2B software deals.
• Mercury Fund: Houston-based early-stage VC investing across Texas with healthcare/tech overlap; comparable check size, regional focus, and stage (seed to Series A), making it a direct peer for Texas early-stage deal competition.
• Biospring Partners: Healthcare-focused early-to-growth stage VC investing in life sciences, medical devices, and tech-enabled healthcare; comparable healthcare-specialist thesis and operator-led approach, though typically larger check sizes than GPG.

Others

• Kauffman Fellows: Venture capital leadership network and talent pipeline (recognized GPG's Claire England with a leadership award); not a direct investor competitor but a peer institution in the VC ecosystem with overlapping talent and portfolio signaling value.

Broad incumbents

• ARCH Venture Partners: Large, established healthcare and technology VC (founded 1986) with much bigger fund sizes and later-stage focus; overlaps with GPG's healthcare thesis at the seed/early end and represents the type of larger firm GPG portfolio companies approach for follow-on rounds.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/gpgventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments93 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Green Park & Golf Ventures